Infrastructure name

    CONGENTO - Consortium for Genetically-Tractable Organisms


    Champalimaud Foundation, Lisbon, Portugal

    Key contact

    Rui M. Costa

    Contact phone number

    351 210480200

    Contact email
    Project/infrastructure description

    The advent of model organisms where genetic manipulations became standard procedures revolutionized biomedical research. Among these organisms, fruitflies (Drosophila melanogaster), zebrafish (Danio rerio), and mice (Mus musculus) have been the most widely used. Studies using genetic manipulations in these species have led to fundamental findings in development, immunology, neuroscience, cancer, etc, that have been recognized with distinctions such as the Nobel Prize and the Lasker Award. They also have led to clinical trials and applications as vast as immunotherapy, chemotherapy, and drugs for psychiatric and cardiovascular disorders. CONGENTO - a Consortium for Genetically Tractable Organisms is the first worldwide infrastructure to integrate the expertise in fruitflies, zebrafish and mice in one research supporting facility. CONGENTO was born from the realization of the needs in Portugal and the opportunity of synergizing efforts by the participating institutions. Three main domains of services were identified as being critically needed in Portugal: 1) maintenance and hosting of genetically modified lines from the 3 species, either live or cryopreserved, 2) generation of new genetic lines and technologies in the different species, and 3) continuous education and certification in animal research and technology. CONGENTO has internationally recognized experts in these 3 domains, and has the combined spatial and equipment resources to support the Portuguese (and also European) Biomedical Research Community. CONGENTO is the first infrastructure in the world to synergize technology development across these 3 species, and provides state of the art services in all 3 organisms.

    Date funding committed


    Date infrastructure operational


    Total capital cost (Euros)

    € 2,476,587

    Does the 'Total Capital Cost' include other associated costs?


    Current infrastructure status


    Is this entry applicable to another section of this questionnaire?

    Further information available at:

    Not applicable

Types: Capital Infrastructure
Member States: Portugal
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF